|
|
|
By Sampatkumarr Govind Donthula, MarketsandMarkets | Explore various manufacturing and synthesis technologies for GLP-1 drugs, along with innovative drug delivery systems and advanced techniques being utilized in their development. | |
|
|
|
One Percent Of A Hundred People's Efforts | By Louis Garguilo, chief editor, Outsourced Pharma | Persephoni BioPartners CEO Hilary Shultz, and newly hired Chief Scientific Officer William Heath – a 34-year veteran of Eli Lilly – explain their biotech-forming business model, dubbed a venture studio, and provide sound advice on working with CDMOs. |
|
|
|
|
|
|
|
|
|
Cambrex Scientist Spotlight: Shawn Conway | Cambrex | Shawn Conway, Senior Director of Operations in High Point, NC, leads a dynamic team of engineers and chemists at Cambrex, focused on supporting clients throughout the entire product life cycle. |
|
|
|
Solid Form Services | Lonza | We have defined work flows to assess and select solid forms in a cost and time efficient manner that meets the needs of each individual program. |
|
|
Capacity Update January 2025: Small Molecule | Upperton Pharma Solutions | Gain insight into the capabilities of our award-winning development and manufacturing facility, which features 10 state-of-the-art GMP manufacturing suites integrated with R&D and QC laboratories. |
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
Connect With Outsourced Pharma: |
|
|
|